Logo CICANCER

MEK5 as a driver in lung cancer

MEK5 as a driver in lung cancer

Adrián Sánchez Fernández

Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca

Date: 13/06/2019
Time: 12:30:00
Salón de actos del Centro de Investigación del Cáncer

Lung cancer is the most common human neoplasia, frequently associated to a dismal outcome. Unfortunately, in advanced stages no efficient therapies are available to fight this devastating disease. Therefore, knowledge of the driving pathophysiological processes is required to raise novel therapeutic strategies. In the work reported here we unveiled an oncogenic role for the protein kinase MEK5 in lung c